Your browser doesn't support javascript.
loading
Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection.
Montes de Oca, Marcela; Kumar, Rajiv; Rivera, Fabian de Labastida; Amante, Fiona H; Sheel, Meru; Faleiro, Rebecca J; Bunn, Patrick T; Best, Shannon E; Beattie, Lynette; Ng, Susanna S; Edwards, Chelsea L; Boyle, Glen M; Price, Ric N; Anstey, Nicholas M; Loughland, Jessica R; Burel, Julie; Doolan, Denise L; Haque, Ashraful; McCarthy, James S; Engwerda, Christian R.
Afiliación
  • Montes de Oca M; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia; School of Medicine, University of Queensland, Brisbane, QLD 4072, Australia.
  • Kumar R; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia; Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India.
  • Rivera FL; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.
  • Amante FH; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.
  • Sheel M; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.
  • Faleiro RJ; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia.
  • Bunn PT; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia; Institute of Glycomics, Griffith University, Gold Coast, Southport, QLD 4215, Australia.
  • Best SE; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.
  • Beattie L; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.
  • Ng SS; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia; School of Natural Sciences, Griffith University, Nathan, QLD 4111, Australia.
  • Edwards CL; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia; School of Medicine, University of Queensland, Brisbane, QLD 4072, Australia.
  • Boyle GM; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.
  • Price RN; Menzies School of Health Research, Darwin, NT 0811, Australia; Charles Darwin University, Darwin, NT 0810, Australia; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7BN, UK.
  • Anstey NM; Menzies School of Health Research, Darwin, NT 0811, Australia; Charles Darwin University, Darwin, NT 0810, Australia.
  • Loughland JR; Menzies School of Health Research, Darwin, NT 0811, Australia; Charles Darwin University, Darwin, NT 0810, Australia.
  • Burel J; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.
  • Doolan DL; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.
  • Haque A; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.
  • McCarthy JS; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia; School of Medicine, University of Queensland, Brisbane, QLD 4072, Australia. Electronic address: j.mccarthy@uq.edu.au.
  • Engwerda CR; QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia. Electronic address: chrise@qimr.edu.au.
Cell Rep ; 17(2): 399-412, 2016 10 04.
Article en En | MEDLINE | ID: mdl-27705789
The development of immunoregulatory networks is important to prevent disease. However, these same networks allow pathogens to persist and reduce vaccine efficacy. Here, we identify type I interferons (IFNs) as important regulators in developing anti-parasitic immunity in healthy volunteers infected for the first time with Plasmodium falciparum. Type I IFNs suppressed innate immune cell function and parasitic-specific CD4+ T cell IFNγ production, and they promoted the development of parasitic-specific IL-10-producing Th1 (Tr1) cells. Type I IFN-dependent, parasite-specific IL-10 production was also observed in P. falciparum malaria patients in the field following chemoprophylaxis. Parasite-induced IL-10 suppressed inflammatory cytokine production, and IL-10 levels after drug treatment were positively associated with parasite burdens before anti-parasitic drug administration. These findings have important implications for understanding the development of host immune responses following blood-stage P. falciparum infection, and they identify type I IFNs and related signaling pathways as potential targets for therapies or vaccine efficacy improvement.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Malaria Falciparum / Interacciones Huésped-Parásitos / Inmunidad Innata Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2016 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Malaria Falciparum / Interacciones Huésped-Parásitos / Inmunidad Innata Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2016 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos